Skip to content
News
We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.
January 25, 2023
Sapphiros Taps Teresa Abraham for VP of Scientific and Technical Affairs
READ MORE
January 20, 2023
Biocrucible, a Sapphiros Company, Appoints Per Grufman as CEO
READ MORE
October 27, 2022
Sapphiros Appoints Mark Gladwell as CEO and President
READ MORE
September 8, 2022
Sapphiros Acquires Flexotronix Limited
READ MORE
September 6, 2022
Mike Musgnug Joins Sapphiros as Executive Vice President, Strategy and CEO, GrapheneDx
READ MORE
August 23, 2022
Satio and Institut Pasteur de Dakar Form Strategic Partnership on Research, Development, Manufacture, and Distribution of Next Generation Healthcare Technologies
READ MORE
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us
Menu
About Sapphiros
Meet Our Team
Our Companies
News
Contact Us